Brain Tumor and Neuro-Oncology Center - Cleveland Clinic

2008 ANNUAL REPORT
Our physicians and healthcare professionals, development teams, fundraisers and leadership
boards collaborate to increase awareness and provide opportunities to support priority research
and clinical initiatives.
Philanthropy
Since 2006, generous supporters have contributed
an additional $1.6 million in outright gifts, pledges
and estate bequests. Of special note are an estate
gift from long-time BTNC benefactor, the late Mel
Burkhardt, annual golf tournament fundraisers held by
Karen Wilson and ongoing research support provided
by the Wolf Family Foundation. This foundation of
philanthropic support has proven critical to the BTNC’s
efforts to advance brain tumor treatment and research.
In addition to financial support, friends also contribute
their time and invaluable service as members of the
Neurological Institute and Taussig Cancer Institute
National Leadership Boards. The BTNC is grateful for
the continued loyalty of many members who served
on the former Brain Tumor Institute Leadership Board.
Many have continued their service on one or both
of these boards as Cleveland Clinic has moved to a
The BTNC is grateful to loyal friends who contribute their time and
invaluable service as members of the Neurological Institute and
Taussig Cancer Institute National Leadership Boards.
multidisciplinary institute model of medicine which
positions the BTNC as part of the Neurological Institute
with strong collaborative ties to the Taussig Cancer
Institute. We are especially grateful to former Brain
Tumor Institute Leadership Board Chair L.B. McKelvey
and member Karen Wilson, who have joined the
Neurological Institute Leadership Board.
All development activities supporting the BTNC are
coordinated by Jason Gray, Associate Chairman of
Institute Development, Institutional Relations and
Development, and Laura Robinson, Senior Director of
Development, Neurological Institute. In collaboration
with physicians and healthcare professionals and
the Taussig Cancer Institute development team, the
fundraisers and leadership boards drive efforts to
increase awareness and provide opportunities for friends
to support priority research and clinical initiatives.
7